CALA
Price:
$0.05
Market Cap:
$243.63K
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the...[Read more]
Industry
Biotechnology
IPO Date
2014-10-02
Stock Exchange
NASDAQ
Ticker
CALA
According to Calithera Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -23541375.00. This represents a change of 53.59% compared to the average of -15327022.00 of the last 4 quarters.
The mean historical Enterprise Value of Calithera Biosciences, Inc. over the last ten years is 98.02M. The current -23541375.00 Enterprise Value has changed -2501.66% with respect to the historical average. Over the past ten years (40 quarters), CALA's Enterprise Value was at its highest in in the September 2017 quarter at 519.32M. The Enterprise Value was at its lowest in in the June 2022 quarter at -25401460.00.
Average
98.02M
Median
74.23M
Minimum
-7998600.00
Maximum
237.48M
Discovering the peaks and valleys of Calithera Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 329.87%
Maximum Annual Enterprise Value = 237.48M
Minimum Annual Increase = -1751.79%
Minimum Annual Enterprise Value = -7998600.00
Year | Enterprise Value | Change |
---|---|---|
2022 | -7511080.00 | 1.98% |
2021 | -7365328.00 | -103.10% |
2020 | 237.48M | 8.98% |
2019 | 217.91M | 127.64% |
2018 | 95.72M | -57.77% |
2017 | 226.67M | 329.87% |
2016 | 52.73M | -60.09% |
2015 | 132.12M | -1751.79% |
2014 | -7998600.00 | -119.77% |
2013 | 40.46M | -43.86% |
The current Enterprise Value of Calithera Biosciences, Inc. (CALA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
74.20M
5-year avg
107.25M
10-year avg
98.02M
Calithera Biosciences, Inc.’s Enterprise Value is less than Abeona Therapeutics Inc. (0), less than Affimed N.V. (224.80M), less than Checkpoint Therapeutics, Inc. (59.03M), less than Adaptimmune Therapeutics plc (104.07M), less than Mereo BioPharma Group plc (101.47M), less than Pieris Pharmaceuticals, Inc. (657.97M), less than PDS Biotechnology Corporation (1.60M), less than Leap Therapeutics, Inc. (79.68M), less than Kodiak Sciences Inc. (32.20M), less than Galmed Pharmaceuticals Ltd. (96.49M), less than Adverum Biotechnologies, Inc. (-816603.00), less than Ardelyx, Inc. (91.97M), less than Zura Bio Limited (1.45B), less than Hepion Pharmaceuticals, Inc. (74.94M), less than AVROBIO, Inc. (1.95M), greater than Verastem, Inc. (-85302404.00), less than null (67.55M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $236.06M | |
224.80M | $61.21M | |
59.03M | $109.02M | |
104.07M | $265.93M | |
101.47M | $739.24M | |
657.97M | $21.34M | |
1.60M | $113.04M | |
79.68M | $110.20M | |
32.20M | $139.96M | |
96.49M | $1.14M | |
-816603.00 | $145.40M | |
91.97M | $1.39B | |
1.45B | $263.39M | |
74.94M | $3.91M | |
1.95M | $5.24M | |
-85302404.00 | $109.06M | |
67.55M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calithera Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Calithera Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Calithera Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Calithera Biosciences, Inc. (CALA)?
What is the 3-year average Enterprise Value for Calithera Biosciences, Inc. (CALA)?
What is the 5-year average Enterprise Value for Calithera Biosciences, Inc. (CALA)?
How does the current Enterprise Value for Calithera Biosciences, Inc. (CALA) compare to its historical average?